Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA Therapy for Oxidative Stress and Inflammation in Type 2 Diabetes
NCT05416580Phase 3Unknown
- Sponsor
- University of Banja Luka
- Start
- Sep 2022
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ursodeoxycholic acid in type 2 diabetes mellitus (T2DM), sponsored by University of Banja Luka. Status: unknown.
02
Drugs
ursodeoxycholic acid
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05416580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05416580.